The role of directional atherectomy in critical-limb ischemia.

IF 2.6 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Prakash Krishnan, Arthur Tarricone, Simon Chen, Samin Sharma
{"title":"The role of directional atherectomy in critical-limb ischemia.","authors":"Prakash Krishnan,&nbsp;Arthur Tarricone,&nbsp;Simon Chen,&nbsp;Samin Sharma","doi":"10.1177/17539447211046953","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Our aim was to review the current literature of the use of directional atherectomy (DA) in the treatment of lower extremity critical-limb ischemia.</p><p><strong>Methods: </strong>A search for relevant literature was performed in PubMed and PubMed Central on 16 April 2020, sorted by best match. Three searches across two databases were performed. Articles were included that contained clinical and procedural data of DA interventions in lower extremity critical-limb ischemia patients. All studies that were systematic reviews were excluded.</p><p><strong>Results: </strong>Eleven papers were included in this review. Papers were examined under several parameters: primary patency and secondary patency, limb salvage/amputation, technical/procedural success, complications/periprocedural events, and mean lesion length. Primary and secondary patency rates ranged from 56.3% to 95.0% and 76.4% to 100%, respectively. Limb salvage rates ranged from 69% to 100%. Lesion lengths were highly varied, representing a broad population, ranging from 30 ± 33 mm to 142.4 ± 107.9 mm.</p><p><strong>Conclusions: </strong>DA may be a useful tool in the treatment of lower extremity critical-limb ischemia.</p>","PeriodicalId":23035,"journal":{"name":"Therapeutic Advances in Cardiovascular Disease","volume":"135 ","pages":"17539447211046953"},"PeriodicalIF":2.6000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dc/96/10.1177_17539447211046953.PMC8606915.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Cardiovascular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17539447211046953","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Our aim was to review the current literature of the use of directional atherectomy (DA) in the treatment of lower extremity critical-limb ischemia.

Methods: A search for relevant literature was performed in PubMed and PubMed Central on 16 April 2020, sorted by best match. Three searches across two databases were performed. Articles were included that contained clinical and procedural data of DA interventions in lower extremity critical-limb ischemia patients. All studies that were systematic reviews were excluded.

Results: Eleven papers were included in this review. Papers were examined under several parameters: primary patency and secondary patency, limb salvage/amputation, technical/procedural success, complications/periprocedural events, and mean lesion length. Primary and secondary patency rates ranged from 56.3% to 95.0% and 76.4% to 100%, respectively. Limb salvage rates ranged from 69% to 100%. Lesion lengths were highly varied, representing a broad population, ranging from 30 ± 33 mm to 142.4 ± 107.9 mm.

Conclusions: DA may be a useful tool in the treatment of lower extremity critical-limb ischemia.

Abstract Image

Abstract Image

Abstract Image

定向动脉粥样硬化切除术在危急肢体缺血中的作用。
背景:我们的目的是回顾目前有关定向动脉粥样硬化切除术(DA)治疗下肢危急肢体缺血的文献。方法:于2020年4月16日在PubMed和PubMed Central检索相关文献,按最佳匹配排序。在两个数据库中执行三次搜索。纳入了包含DA干预在下肢危急肢体缺血患者中的临床和手术资料的文章。所有系统评价的研究都被排除在外。结果:共纳入11篇论文。论文根据几个参数进行审查:原发性通畅和继发性通畅,肢体保留/截肢,技术/手术成功,并发症/手术期间事件,平均病变长度。原发性和继发性通畅率分别为56.3% ~ 95.0%和76.4% ~ 100%。残肢保留率从69%到100%不等。病变长度变化很大,代表了广泛的人群,范围从30±33 mm到142.4±107.9 mm。结论:DA可能是治疗下肢危急肢体缺血的有效工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Cardiovascular Disease
Therapeutic Advances in Cardiovascular Disease CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.50
自引率
0.00%
发文量
11
审稿时长
9 weeks
期刊介绍: The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: ·arteriosclerosis ·cardiomyopathies ·coronary artery disease ·diabetes ·heart failure ·hypertension ·metabolic syndrome ·obesity ·peripheral arterial disease ·stroke ·arrhythmias ·genetics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信